Cynthia A Sanoski1. 1. Department of Pharmacy Practice, Jefferson School of Pharmacy, Thomas Jefferson University, Philadelphia, PA 19107-5233, USA. cynthia.sanoski@jefferson.edu
Abstract
PURPOSE: To describe the prevalence, pathophysiology, and consequences of atrial fibrillation (AF) and the risk factors for the rhythm disturbance. SUMMARY: The prevalence of AF, a common age-related disorder that causes substantial morbidity and mortality, is increasing. Structural heart disease (e.g., coronary heart disease, hypertension, heart failure, valvular heart disease) is a common comorbidity of and risk factor for AF, although various other factors have been shown to play a role in the pathogenesis of this disorder. The risk for AF and ischemic stroke, a major complication of AF, can be estimated using risk-scoring systems. The rate of hospitalization for AF and the costs of treating AF are increasing in the United States. CONCLUSION: Understanding the pathogenesis of and risk factors for AF and using risk-scoring systems to estimate the risk for AF and stroke can facilitate treatment of this rhythm disorder and potentially minimize its morbidity, mortality, and costs.
PURPOSE: To describe the prevalence, pathophysiology, and consequences of atrial fibrillation (AF) and the risk factors for the rhythm disturbance. SUMMARY: The prevalence of AF, a common age-related disorder that causes substantial morbidity and mortality, is increasing. Structural heart disease (e.g., coronary heart disease, hypertension, heart failure, valvular heart disease) is a common comorbidity of and risk factor for AF, although various other factors have been shown to play a role in the pathogenesis of this disorder. The risk for AF and ischemic stroke, a major complication of AF, can be estimated using risk-scoring systems. The rate of hospitalization for AF and the costs of treating AF are increasing in the United States. CONCLUSION: Understanding the pathogenesis of and risk factors for AF and using risk-scoring systems to estimate the risk for AF and stroke can facilitate treatment of this rhythm disorder and potentially minimize its morbidity, mortality, and costs.
Authors: Faye L Lopez; Sunil K Agarwal; Morgan E Grams; Laura R Loehr; Elsayed Z Soliman; Pamela L Lutsey; Lin Y Chen; Rachel R Huxley; Alvaro Alonso Journal: Am J Cardiol Date: 2012-12-28 Impact factor: 2.778
Authors: Faye L Lopez; Sunil K Agarwal; Richard F Maclehose; Elsayed Z Soliman; A Richey Sharrett; Rachel R Huxley; Suma Konety; Christie M Ballantyne; Alvaro Alonso Journal: Circ Arrhythm Electrophysiol Date: 2012-01-06
Authors: Mary P Panaccio; Gordon Cummins; Charles Wentworth; Stephan Lanes; Shannon L Reynolds; Matthew W Reynolds; Raymond Miao; Andrew Koren Journal: Clin Epidemiol Date: 2015-01-12 Impact factor: 4.790
Authors: Faye L Norby; Elsayed Z Soliman; Lin Y Chen; Lindsay G S Bengtson; Laura R Loehr; Sunil K Agarwal; Alvaro Alonso Journal: Circulation Date: 2016-08-23 Impact factor: 29.690
Authors: Faye L Norby; Samuel Adamsson Eryd; Maartje N Niemeijer; Lynda M Rose; Albert V Smith; Xiaoyan Yin; Sunil K Agarwal; Dan E Arking; Daniel L Chasman; Lin Y Chen; Mark Eijgelsheim; Gunnar Engström; Oscar H Franco; Jan Heeringa; George Hindy; Albert Hofman; Pamela L Lutsey; Jared W Magnani; David D McManus; Marju Orho-Melander; James S Pankow; Gull Rukh; Christina-Alexandra Schulz; André G Uitterlinden; Christine M Albert; Emelia J Benjamin; Vilmundur Gudnason; J Gustav Smith; Bruno H C Stricker; Alvaro Alonso Journal: PLoS One Date: 2016-03-21 Impact factor: 3.240